AC
CLVS

Antara Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Antara Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$404K – 47
2019
Q2 		$743K Buy
50,000
+15,000
+43% +$271K 0.16% 47
2019
Q1 		$868K Sell
35,000
-84,800
-71% -$2.13M 0.24% 41
2018
Q4 		$2.15M Buy
+119,800
New +$2.45M 1.47% 17

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Antara Capital's CLVS Position: Q3 2019 in Review

Antara Capital sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 50,000 shares — an estimated $404K sold.

Antara Capital first reported a position in CLVS in Q4 2018 and held it in 3 quarters. The position peaked at $2.15M in Q4 2018. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • Antara Capital reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • Antara Capital sold 50,000 Clovis Oncology, Inc. shares in Q3 2019, an estimated $404K.
  • Antara Capital first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 3 quarters.
  • Antara Capital's Clovis Oncology, Inc. position peaked at $2.15M in Q4 2018.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Antara Capital's 13F filing for Q3 2019, filed 14 Nov 2019.